Improving Adherence to Chronic Disease Medication Regimens Among Patients With Recently Diagnosed Cancer
Recruiting
N/A
Interventional Study
Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- Duke University · Other
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This pilot study evaluates a pharmacist-led medication adherence intervention and Medisafe mobile application among patients with newly diagnosed cancer and multimorbidity. Thirty participants will be randomized to intervention or usual care to assess feasibility, acceptability, usability, and preliminary efficacy.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* diagnosed with breast, colorectal, lung or prostate cancer in the previous 12 months
* had no prior diagnosis of cancer
* are currently undergoing chemotherapy or radiation and/or underwent surgery in the prior 3 months
* had \>2 chronic conditions for \>1 year prior to cancer…
Contacts
No contact information available.